Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021
- Resource Type
- Source
- Eurosurveillance
Eurosurveillance, 2021, 26 (9), ⟨10.2807/1560-7917.ES.2021.26.9.2100133⟩
Eurosurveillance, European Centre for Disease Prevention and Control, 2021, 26 (9), ⟨10.2807/1560-7917.ES.2021.26.9.2100133⟩ - Subject
Author's Correction Paris medicine.medical_specialty 2019-20 coronavirus outbreak Lineage (genetic) Coronavirus disease 2019 (COVID-19) Epidemiology Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral infections [SDV]Life Sciences [q-bio] Context (language use) Biology 03 medical and health sciences 0302 clinical medicine Virology medicine Humans MESH: COVID-19 MESH: SARS-CoV-2 030212 general & internal medicine 030304 developmental biology COVID [SDV.MHEP.ME] Life Sciences [q-bio]/Human health and pathology/Emerging diseases [SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/Virology 0303 health sciences [SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases MESH: Humans SARS-CoV-2 MESH: Paris Public Health, Environmental and Occupational Health COVID-19 [SDV] Life Sciences [q-bio] MESH: France 20I/501Y.V1 [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology surveillance France mutation Rapid Communication Demography - Language
- English
- ISSN
- 1560-7917
1025-496X